Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-151796

Flexion Therapeutics Inc · FLXN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Samuel D Colella
Director · 10% Owner
Period of report
Nov 21, 2016
Accepted (ET)
Nov 22, 2016 · 6:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419600

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Nov 21, 2016P33,333$18.00A33,333IBy Colella Family Trust
Common Stockholding———25,504D
Common StockF2holding———3,511,670ISee Footnote
Common StockF3holding———20,739ISee Footnote
Common StockF4holding———388,683ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses